Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial

Signe Kaas Møller-Bisgaard; K Hørslev-Petersen; Lykke Midtbøll Ørnbjerg; Bo Ejbjerg; Merete Lund Hetland; J. E. Moeller; R. Christensen; Stine Mai Nielsen; Daniel Erik Glinatsi; Mikael Boesen; K Stengaard-Pedersen; Ole Rintek Madsen; B. Jensen; J. A. Villadsen; E M Hauge; Oliver Hendricks; H.M. Lindegaard; N S Krogh; Anne Grethe Jurik; H Thomsen; Mikkel Østergaard

Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial

Signe Kaas Møller-Bisgaard
, K Hørslev-Petersen
, Lykke Midtbøll Ørnbjerg
, Bo Ejbjerg
, Merete Lund Hetland
, J. E. Moeller
, R. Christensen
, Stine Mai Nielsen
, Daniel Erik Glinatsi
, Mikael Boesen
, K Stengaard-Pedersen
, Ole Rintek Madsen
, B. Jensen
, J. A. Villadsen
, E M Hauge
, Oliver Hendricks
, H.M. Lindegaard
, N S Krogh
, Anne Grethe Jurik
, H Thomsen

Originalsprog	Engelsk
Publikationsdato	2023
Status	Udgivet - 2023
Begivenhed	ACR Convergence 2023 - San Diego, USA Varighed: 10 nov. 2023 → 15 nov. 2023

Konference

Konference	ACR Convergence 2023
Land/Område	USA
By	San Diego
Periode	10/11/2023 → 15/11/2023

Citationsformater

Møller-Bisgaard, S. K., Hørslev-Petersen, K., Ørnbjerg, L. M., Ejbjerg, B., Hetland, M. L., Moeller, J. E., Christensen, R., Nielsen, S. M., Glinatsi, D. E., Boesen, M., Stengaard-Pedersen, K., Madsen, O. R., Jensen, B., Villadsen, J. A., Hauge, E. M., Hendricks, O., Lindegaard, H. M., Krogh, N. S., Jurik, A. G., ... Østergaard, M. (2023). Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial. Arthritis & Rheumatology 75 (suppl 9), abstract no 1868. Abstract fra ACR Convergence 2023, San Diego, USA.

Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial. / Møller-Bisgaard, Signe Kaas; Hørslev-Petersen, K; Ørnbjerg, Lykke Midtbøll et al.
2023. Arthritis & Rheumatology 75 (suppl 9), abstract no 1868 Abstract fra ACR Convergence 2023, San Diego, USA.

Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

Møller-Bisgaard, SK, Hørslev-Petersen, K, Ørnbjerg, LM, Ejbjerg, B, Hetland, ML, Moeller, JE, Christensen, R, Nielsen, SM, Glinatsi, DE , Boesen, M, Stengaard-Pedersen, K, Madsen, OR, Jensen, B, Villadsen, JA, Hauge, EM, Hendricks, O, Lindegaard, HM, Krogh, NS, Jurik, AG, Thomsen, H & Østergaard, M 2023, 'Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial', ACR Convergence 2023, San Diego, USA, 10/11/2023 - 15/11/2023 s. Arthritis & Rheumatology 75 (suppl 9), abstract no 1868.

Møller-Bisgaard SK, Hørslev-Petersen K, Ørnbjerg LM, Ejbjerg B, Hetland ML, Moeller JE et al.. Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial. 2023. Abstract fra ACR Convergence 2023, San Diego, USA.

@conference{ca6e6a73aa4745ebad5ccb59ccc4d893,

title = "Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission {\textendash} Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial",

author = "M{\o}ller-Bisgaard, \{Signe Kaas\} and K H{\o}rslev-Petersen and {\O}rnbjerg, \{Lykke Midtb{\o}ll\} and Bo Ejbjerg and Hetland, \{Merete Lund\} and Moeller, \{J. E.\} and R. Christensen and Nielsen, \{Stine Mai\} and Glinatsi, \{Daniel Erik\} and Mikael Boesen and K Stengaard-Pedersen and Madsen, \{Ole Rintek\} and B. Jensen and Villadsen, \{J. A.\} and Hauge, \{E M\} and Oliver Hendricks and H.M. Lindegaard and Krogh, \{N S\} and Jurik, \{Anne Grethe\} and H Thomsen and Mikkel {\O}stergaard",

note = "COPECARE; ACR Convergence 2023 ; Conference date: 10-11-2023 Through 15-11-2023",

year = "2023",

language = "English",

pages = "Arthritis \& Rheumatology 75 (suppl 9), abstract no 1868",

}

TY - ABST

T1 - Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission – Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial

AU - Møller-Bisgaard, Signe Kaas

AU - Hørslev-Petersen, K

AU - Ørnbjerg, Lykke Midtbøll

AU - Ejbjerg, Bo

AU - Hetland, Merete Lund

AU - Moeller, J. E.

AU - Christensen, R.

AU - Nielsen, Stine Mai

AU - Glinatsi, Daniel Erik

AU - Boesen, Mikael

AU - Stengaard-Pedersen, K

AU - Madsen, Ole Rintek

AU - Jensen, B.

AU - Villadsen, J. A.

AU - Hauge, E M

AU - Hendricks, Oliver

AU - Lindegaard, H.M.

AU - Krogh, N S

AU - Jurik, Anne Grethe

AU - Thomsen, H

AU - Østergaard, Mikkel

N1 - COPECARE

PY - 2023

Y1 - 2023

M3 - Conference abstract for conference

SP - Arthritis & Rheumatology 75 (suppl 9), abstract no 1868

T2 - ACR Convergence 2023

Y2 - 10 November 2023 through 15 November 2023

ER -